According to FutureWise analysis the market for cell dissociation in 2023 is US$ 0.6 billion, and is expected to reach US$ 2.26 billion by 2031 at a CAGR of 18%.
Cell dissociation is an essential laboratory process that separates adherent or clustered cells into a single-cell suspension. This procedure is vital for various biological and medical research applications, including cell culture, flow cytometry, single-cell analysis, regenerative medicine, and drug discovery. By breaking down the extracellular matrix and intercellular connections, cell dissociation enables scientists to isolate viable, individual cells for further experimentation and analysis.
Cell dissociation can be performed using mechanical, enzymatic, or chemical methods—or a combination of these techniques—depending on the cell type and its sensitivity. Mechanical dissociation involves physical disruption, such as pipetting or mincing. Enzymatic methods use enzymes like trypsin, collagenase, or dispase to degrade the proteins that hold cells together. Conversely, chemical dissociation employs chelating agents, such as EDTA, to weaken calcium-dependent cell adhesion. Each approach must be carefully optimized to maintain cell viability, functionality, and genetic integrity.
In recent years, advancements in automated cell dissociation systems and enzyme-free reagents have improved precision, reproducibility, and scalability—especially in clinical and biopharmaceutical research. Single-cell technologies, such as single-cell RNA sequencing, have further increased the demand for gentle, efficient dissociation techniques that preserve cell morphology and surface markers.
Overall, cell dissociation is a foundational step in cellular biology, facilitating the transition from complex tissue structures to uniform single-cell populations. This process supports a wide range of downstream applications—from basic research and diagnostics to cell therapy and tissue engineering—making it indispensable for modern biomedical science and innovation.
FutureWise Market Research has published a report that provides an insightful analysis of Cell Dissociation Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=10626&type=requestsample
Cell Dissociation Market Segmentation:
By Product
- Enzymatic Dissociation Products
- Collagenase
- Trypsin
- Elastase
- Papain
- Hyaluronidase
- DNase
- Other Enzymes
- Non-enzymatic Dissociation Products
- Instruments and Accessories
By Tissue
- Connective Tissue
- Epithelial Tissue
- Other Tissue
By Type
- Tissue Dissociation
- Cell Detachment
By End User
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
- Other End Users
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Cell Dissociation Market:
- BD
- Thermo Fisher Scientific
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Merck KGaA
- ATCC
- Himedia Laboratories
- Pan-Biotech
- Miltenyi Biotec
- Stemcell Technologies
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10626&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Cell Dissociation Market By Product, By Tissue, By Type, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
